Kota Iwahori
Overview
Explore the profile of Kota Iwahori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hara R, Takeda Y, Enomoto T, Yoshimura H, Yamamoto M, Tanizaki S, et al.
J Allergy Clin Immunol Glob
. 2025 Mar;
4(2):100432.
PMID: 40046156
Background: Bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) are often misdiagnosed or undiagnosed, highlighting the need for more noninvasive and accessible diagnostic tools. Although exhaled breath condensate (EBC)...
2.
Tone M, Isono T, Yamamoto Y, Takeda Y, Shintani Y, Kumanogoh A, et al.
Anticancer Res
. 2025 Mar;
45(3):909-920.
PMID: 40037874
Background/aim: Previous investigations showed that non-small cell lung cancer (NSCLC) patients with a high percentage of a peripheral CD4 T cell subset were more likely to have severe immune-related adverse...
3.
Naito M, Takeda Y, Edahiro R, Shirai Y, Enomoto T, Nakayama M, et al.
Int J Mol Sci
. 2025 Feb;
26(3).
PMID: 39940923
Nontuberculous mycobacterial pulmonary disease (NTM-PD), mainly caused by complex (MAC), and pulmonary tuberculosis (TB) are emerging health problems worldwide. However, because their clinical features are often similar, it remains difficult...
4.
Adachi Y, Miyake K, Ohira K, Satoh S, Masuhiro K, Edahiro R, et al.
EBioMedicine
. 2025 Jan;
112:105566.
PMID: 39848206
Background: Photoimmunotherapy (PIT) is a potent modality for cancer treatment. The conventional PIT regimen involves the systemic delivery of an antibody-photoabsorber conjugate, followed by a 24-h waiting period to ensure...
5.
Yamamoto Y, Iwahori K, Shintani Y
Mediastinum
. 2025 Jan;
8():47.
PMID: 39781199
Background And Objective: Thymic epithelial tumors (TETs) are the most common neoplasm of the prevascular mediastinal compartment and are characterized by their rarity and variable clinical presentation. The present study...
6.
Matsuda H, Iwahori K, Takeoka T, Kato R, Urakawa S, Saito T, et al.
Anticancer Res
. 2024 Aug;
44(9):3799-3805.
PMID: 39197894
Background/aim: We herein examined T cell immunity in esophageal cancer patients with and without Helicobacter pylori infection to establish a foundation for immunotherapeutic strategies targeting esophageal cancer in the presence...
7.
Enomoto T, Shirai Y, Takeda Y, Edahiro R, Shichino S, Nakayama M, et al.
JCI Insight
. 2024 Jun;
9(11).
PMID: 38855869
Progressive pulmonary fibrosis (PPF), defined as the worsening of various interstitial lung diseases (ILDs), currently lacks useful biomarkers. To identify novel biomarkers for early detection of patients at risk of...
8.
Hayashi Y, Ueyama A, Funaki S, Jinushi K, Higuchi N, Morihara H, et al.
BMC Cancer
. 2024 May;
24(1):627.
PMID: 38783281
Background: CCR8-expressing regulatory T cells (Tregs) are selectively localized within tumors and have gained attention as potent suppressors of anti-tumor immunity. This study focused on CCR8 Tregs and their interaction...
9.
Tone M, Iwahori K, Hirata M, Ueyama A, Tani A, Haruta J, et al.
J Immunother Cancer
. 2024 Apr;
12(4).
PMID: 38621815
Background: Cancer immunotherapy including immune checkpoint inhibitors is only effective for a limited population of patients with cancer. Therefore, the development of novel cancer immunotherapy is anticipated. In preliminary studies,...
10.
Yoshimura H, Takeda Y, Shirai Y, Yamamoto M, Nakatsubo D, Amiya S, et al.
J Allergy Clin Immunol
. 2024 Mar;
153(5):1268-1281.
PMID: 38551536
Background: Novel biomarkers (BMs) are urgently needed for bronchial asthma (BA) with various phenotypes and endotypes. Objective: We sought to identify novel BMs reflecting tissue pathology from serum extracellular vesicles...